Abeliophyllum distichum Nakai alleviates postmenopausal osteoporosis in ovariectomized rats and prevents RANKL-induced osteoclastogenesis in vitro
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 257, 112828
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Education (2017R1D1A1B03028505)
This publication has 42 references indexed in Scilit:
- Induction of Functional Human Macrophages from Bone Marrow Promonocytes by M-CSF in Humanized MiceThe Journal of Immunology, 2013
- Therapeutic inhibition of cathepsin K—reducing bone resorption while maintaining bone formationBoneKEy Reports, 2012
- Cellular mechanisms of bone remodelingReviews in Endocrine and Metabolic Disorders, 2010
- Bone Mineral Density Changes after Ovariectomy in Rats as an Osteopenic Model : Stepwise Description of Double Dorso-Lateral ApproachJournal of Korean Neurosurgical Society, 2010
- NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)Molecular Endocrinology, 2008
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Receptor activator of NF-κB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cellsLife Sciences, 2007
- Four glycosides from the leaves of Abeliophyllum distichum with inhibitory effects on angiotensin converting enzymePhytotherapy Research, 2003
- Osteoclast differentiation and activationNature, 2003
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO reportOsteoporosis International, 1994